ASX 200 listed IT solutions provider Data#3 has announced its interim results for the first half of its 2025 financial year, ...

Q4 2024. Management View. CEO Jim Kessler highlighted a strong Q4 performance with a 13% increase in adjusted EBITDA and a 2% gr ...

Australian shares are trading notably lower on Wednesday, extending the losses in the previous two sessions, with the benchmark ...

Australian stock futures are pointing to a slightly soft open for the S&P/ASX 200 after the country’s central bank warned that its first interest-rate cut since 2025 may not be followed by more.

It feels like investors have finally woken up to the fact that bank share prices have been unfathomably overvalued for a year ...

CSL and Cochlear are two of Australia’s blue-chip healthcare stocks, stalwarts of many investors portfolios, whereas Pro ...

Two popular ETFs used for US exposure are iShares S&P 500 ETF (ASX: IVV) and Vanguard US Total Market Shares ETF (ASX: VTS).

The popularity of ETFs is constantly rising as investors gain confidence in the increasing number of ETFs delivering ...

The Australian stock market has reached new record highs, driven by strong performances across multiple sectors, notably ...

The banking giant has doubled in value in the past year but fell 5% or 16p to 291.75p, despite 2024 figures showing a 24% ...

The local share market has pushed further into record territory amid potential peace negotiations between Russia and Ukraine, ...

The S&P/ASX 200 Index (ASX: XJO) healthcare stock has delivered sizzling gains over the short and long term. Here’s how.